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Condensation:  
Different fibroid characteristics affect pregnancy outcome in varying ways and this 
information can be used to aid counselling women antenatally and in risk stratifying patients. 
 
Short Version of Title:  
Fibroids and pregnancy outcome 
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Abstract 
Objective: To assess the influence of different characteristics of fibroids on pregnancy 
outcome. 
Study design: We identified women with fibroids ≥4 cm in size on ultrasonography at the 
dating scan between January 2002 and December 2012. The size (4-7cm, 7-10cm, >10cm), 
number (multiple/single), location (lower uterus/body of uterus) and type (intramural, 
combination of intramural/subserosal, subserosal) were ascertained.  Medical records were 
reviewed to obtain pregnancy outcomes (preterm delivery, birth weight, mode of delivery, 
estimated blood loss, postpartum haemorrhage and admission for fibroid related pain). 
Results: 121 patients with 179 pregnancies were identified. Preterm delivery was more likely 
in those with multiple fibroids compared to single fibroids (18% v 6% p=0.05). The location 
of fibroid had an important effect on mode of delivery with a higher caesarean section rate for 
fibroids in the lower part of uterus than in the body of the uterus (86% v 40% p=0.01), a 
higher rate of postpartum haemorrhage (22% v 11%p=0.03) and greater estimated blood loss 
(830 mls (standard deviation [SD] 551) v. 573 mls (SD 383) p=0.03). Increasing size of 
fibroid was associated with greater rates of haemorrhage (11% v. 13% v. 36% p=0.04), 
increased estimated blood loss (567 mls (SD 365) v. 643 mls (SD 365) v. 961 mls (SD 764) 
p=0.01) and higher rates of admissions for fibroid related pain (5% v 23% v. 21% p=0.01). 
Conclusions: Different fibroid characteristics affect pregnancy outcome in varying ways. 
This information can be used to aid counselling women antenatally and in risk stratifying 
patients. 
 
Key words: Fibroid, leiomyoma, pregnancy  
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Introduction 
Fibroids, or leiomyomas are benign tumours of the smooth muscle layer of the uterus. The 
precise aetiology of fibroids is still unknown, but it is clear that oestrogen and progesterone 
can cause growth1, 2. They are common in women of child-bearing age and have an overall 
incidence of 40-60% by 35 years of age3.   
Depending upon the trimester of assessment and the size threshold, the prevalence of fibroids 
in pregnancy varies between 1.2 and 10.7%4-7. Visualisation of fibroids in pregnancy can be 
problematic partly because of the difficulty of ultrasonography in differentiating fibroids 
from physiological thickening of the myometrium4, 8. It is therefore likely that the prevalence 
of fibroids in pregnancy is underestimated. Although the majority of women with fibroids 
will have uneventful pregnancies, approximately 10-28% of women will develop 
complications usually in the form of abdominal pain9-12, caused by either fibroid red-
degeneration (necrosis of the fibroid as it overgrows its blood supply), torsion of 
pedunculated fibroids or impaction.  
There is conflicting evidence on the impact of fibroids on pregnancy, and the mechanism by 
which fibroids influence adverse obstetric outcome is not clearly understood. Some studies 
suggest that there is an increase in the rates of miscarriage, preterm labour/delivery and 
haemorrhage13. What is even less well described in the literature is the effect of size, number, 
location and type of fibroid (i.e. submucosal, intramural or subserosal) on complications 
during pregnancy and obstetric outcome. The aim of this study was to assess and evaluate the 
impact of different characteristics of large fibroids (defined as >4 cm) on pregnancy outcome. 
 
  
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 
   5 
 
Materials and Methods 
This was a retrospective observational study of all pregnancies with uterine fibroids ≥ 4cm 
detected on booking (first trimester) antenatal ultrasound performed by accredited 
sonographers at a major tertiary referral centre (Queen Charlotte’s and Chelsea Hospital) 
between January 2002 and December 2012. Data was extracted from the obstetric ultrasound 
database (Astraia, Munich, Germany). The size (4-7cm, >7-10 cm, >10 cm in greatest 
dimension), location (lower uterus or body of uterus), type (submucosal, intramural, 
subserosal or varying combinations) of the fibroids as well as whether they were single or 
multiple (≥ 2 fibroids) were noted. Obstetric and neonatal outcomes were ascertained from 
the maternity database and chart review. In particular, rates of preterm delivery (< 37 weeks), 
postpartum haemorrhage (estimated blood loss ≥ 1000ml for caesarean and vaginal delivery), 
and antenatal admissions for abdominal pain due to fibroids were collected. The mode of 
delivery, estimated blood loss at delivery and birth weight were additional outcome measures 
which were assessed.  As this study was part of a clinical audit, formal research ethics 
approval was not required.  
Statistical analyses included the chi-squared test, student t-test and analysis of variance 
(ANOVA). Significant differences were considered when p ≤ 0.05. 
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Results 
During the study period, 197 patients were identified with fibroids ≥ 4cm confirmed on 
ultrasound. Of these, data was only available for 121 patients with 179 pregnancies. There 
were 136 live births, 22 miscarriages, 7 ectopic pregnancies, 2 stillbirths, 3 terminations of 
pregnancy and 9 unknown outcomes. Of the 121 patients, 66 (55%) patients were of 
African/Caribbean origin, 39 (32%) were Caucasian and 16 (13%) were Asian.  
Forty nine (40%) patients had a single fibroid whilst 72 (60%) patients had multiple fibroids. 
Fibroids were found to be subserosal in 30 patients (25%), intramural in 40 patients (33%), a 
combination of intramural and subserosal in 43 patients (35.5%), submucosal in 1 patient 
(0.8%) and undocumented in 7 patients (5.7%). Twenty three patients (19%) were found to 
have fibroids in the lower uterus or on/adjacent to the cervix.  
The median maternal age was 32 years (range 20-46 years).  The overall median gestation at 
birth was 39 weeks (range 24-41 weeks). There were 18 (13%) preterm deliveries (<37 
weeks). The median birth weight was 3.169 kg (range 0.62 – 5.728kg). There were 50 
(50/136, 37%) spontaneous vaginal deliveries, 17 (17/136, 13%) instrumental deliveries, and 
69 (69/136, 50%) caesarean sections, of which 38 (55%) were elective and 31 (45%) were 
emergency cases.  
The indications for elective caesarean sections included malpresentation (n=6, 16%), multiple 
pregnancy (n=2, 5%), previous caesarean section (n=13, 34%), placenta praevia (n=4, 10%), 
macrosomia (n=1, 3%), retroviral disease (n=1, 3%), oligohydramnios (n=1, 3%) and 
unknown in 3 cases (8%). The presence of fibroids as the primary indication for elective 
caesarean section only occurred in 7 (18%) cases. The indications for emergency caesarean 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 
   7 
 
section included failure to progress (n=14, 45%), fetal distress (n=12, 39%), severe pre-
eclampsia (n=3, 10%), and unknown in 2 (6%) cases. 
The overall mean estimated blood loss was 636 mls (SD 445ml), and there were 19 cases 
(19/136, 14%) of postpartum haemorrhage (PPH). There were 15 admissions (15/136, 11%) 
due to abdominal pain from fibroids. 
 
Number of fibroids 
Patients with multiple fibroids (defined as ≥ 2 fibroids) were significantly more likely to have 
a preterm birth compared to women with a single fibroid (18% v 6%, p = 0.05) (Table 1). 
Although the rate of caesarean section was higher (55% v 45%) in women with multiple 
fibroids compared to those with a single fibroid, this difference was not significant (p=0.31). 
Mean birth weight was 3.00 kg (SD 0.865 kg) in women with multiple fibroids compared 
with 3.18 kg (SD 0.653kg) with single fibroids, a difference which was again not significant 
(p >0.5). The rate of PPH was similar between the two groups (15% (multiple fibroids), v 
12% (single fibroid), p=0.57), as was the mean estimated blood loss between the two groups 
(642 mls (SD 425 mls) v 639 mls (SD 480 mls) p >0.2). There were similar rates of 
admissions (12% v 10%, p=0.72) due to fibroid related abdominal pain.  
 
Location of fibroids within the uterus 
There was no difference in mean birth weight with different locations of the fibroid (Table 2). 
The location of fibroid (lower uterus/cervix v. body of uterus) did not have a statistically 
significant impact on the rate of preterm delivery (8% v 14%, p=0.5). However, cases where 
the fibroids were in the lower part of the uterus were significantly more likely to have a 
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caesarean section (86% v 40%, p=0.01). Of those women with lower uterine fibroids who had 
caesarean section, 8/26 (31%) had an emergency caesarean section and 18/26 (69%) had 
elective caesarean sections (4 due to fibroids, 6 due to malpresentation, 5 for previous 
caesarean section, 2 for placenta praevia and 1 for multiple pregnancy). The mean estimated 
blood loss was higher in those women with fibroids in the lower part of the uterus (830 mls 
[SD 551 mls]) compared to in the body of the uterus (573 mls [SD 383 mls]) p=0.03, and the 
incidence of postpartum haemorrhage was significantly increased when the fibroids were in 
the lower part of the uterus (22% v 11%, p=0.03). There were no significant differences 
found between the different locations of fibroids for rates of admissions for fibroid related 
pain (5% (lower uterus) v. 12.5% (body of uterus) p = 0.35). 
 
Type of fibroid 
There was no difference in birth weight or rates of preterm delivery between subserosal and 
intramural fibroids (Table 3). However, although women with intramural fibroids had 
substantially higher rates of caesarean sections compared with women in whom the fibroids 
were solely subserosal, this difference was not significant (47% (intramural), 61% 
(combination of intramural and subserosal) v 34% (subserosal) p=0.059). Fibroids which 
were solely subserosal were associated with a lower blood loss than those which were 
intramural. This difference was however not statistically significant (507 mls (SD 312 mls) 
[subserosal] v. 606 mls (SD 364 mls) [combination of intramural and subserosal] and 751 mls 
(SD 582 mls) [intramural], p=0.09). There was no significant effect on rates of postpartum 
haemorrhage (9% (intramural) v. 14% (combination of intramural and subserosal) v. 6% 
(subserosal) p = 0.53) and admissions for fibroid related abdominal pain (16% (intramural) v. 
10% (combination of intramural and subserosal) v. 6% (subserosal) p = 0.36). 
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Size of fibroid 
Fibroid size was categorized into 3 groups (4-7 cm, 7 -10 cm and >10 cm). Fibroid size did 
not affect the mean birthweight, rate of preterm delivery or the mode of delivery (Table 4). 
However, the rates of postpartum haemorrhage were higher (11% (4-7 cm) v. 13% (7-10 cm) 
v. 36% (>10 cm) p=0.04) and mean estimated blood loss was greater (567 mls (SD 365 mls) 
[4-7 cm] v. 643 mls (SD 365 mls) [7-10 cm] v. 961 mls (SD 764 mls) [> 10cm] p=0.01) with 
increasing size of fibroid. Smaller fibroids i.e. 4-7 cm in size were less likely to result in 
admissions for fibroid related pain (5% (4-7 cm) v. 23% (7-10 cm) v. 21% (>10 cm) p=0.01). 
 
 
 
Comment 
There is inconsistent data regarding the impact of fibroids on pregnancy, and even less 
information on how different characteristics of fibroids influence obstetric outcome. This 
large retrospective study attempts to address this. 
Diagnosis of small fibroids (<5cm) either by ultrasound is known to be inaccurate, especially 
in pregnancy due to the difficulty in distinguishing fibroids from physiological thickening of 
the myometrium. In this study we only included fibroids larger than 4cm in size, so that our 
findings would have greater clinical relevance. We concentrated on important outcomes, such 
as preterm delivery, intrauterine growth restriction, mode of delivery and postpartum 
haemorrhage. Furthermore, we have tried to correlate these outcomes with different aspects 
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of fibroids (size, location, type, number), which thus far has not been clearly elucidated from 
previous studies.  
The overall rate of preterm delivery in this study was 13% (18/136), and the rate of caesarean 
section was 51% (69/136) which is consistent with previously published data13. However, 
there was a high rate of postpartum haemorrhage in our cohort (14%, 19/136), compared to 
2.5% as suggested in the systematic review by Klatsky et al13. This difference could be 
explained by differing definitions of postpartum haemorrhage or varying institutional 
reporting rates. In our series, the rate of admissions from fibroid related pain was 11% 
(15/136), similar to that previously reported by other authors (10-13). Our data also confirms 
that the rate of fetal growth restriction in pregnancies is not increased in pregnancies 
complicated with fibroids. 
We found preterm delivery was significantly more likely with multiple fibroids than if the 
fibroids were solitary (18% v 6%, p=0.05) which was also described by Lev-Toaff et al11. 
However, the location within the uterus, size and type of fibroid was not found to influence 
the rate of pre-term delivery, findings which have not previously been reported. 
Caesarean section was significantly more likely if the fibroids were in the lower part of the 
uterus, which is consistent with findings by Lev-Toaff et al11 and Vergani et al14. However, 
our findings did not show a relationship between mode of delivery and the number of 
fibroids, which conflicts with previously reported findings7, 11. Although some studies12, 14 
suggested that larger fibroids were more likely to be associated with operative delivery, we 
could not demonstrate a similar association. In fact, our data support the conclusions of a 
study by Roberts et al15 where multiple or larger fibroids were not associated with increased 
risk of caesarean section. Furthermore, current obstetric practice is that large fibroids or the 
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presence of multiple fibroids are not an immediate contra-indication to a trial of labour16, and 
our results supports this rationale. 
Although the risk of hysterectomy has been demonstrated to be higher in women with 
fibroids13, 17, 18, the data on risk of postpartum haemorrhage are not consistent, with some 
studies demonstrating no increase in rates of haemorrhage15, 19. The results from our study 
suggest that only the size and its location within the uterus influences the risk of 
haemorrhage. This association of different features of fibroids with postpartum haemorrhage 
has not been previously shown before, and may be useful in providing information to women 
and can also aid clinical practice in helping to identify those most at risk of postpartum 
haemorrhage. 
Pain is the commonest complication of fibroids during pregnancy that women report.  Our 
data shows that abdominal pain from fibroids requiring admission was more likely with 
increasing fibroid size, which is consistent with previous reports10, 17. No correlation was 
found with the type, number or location of fibroid.   
Women should be reassured that the majority of pregnancies with fibroids have good 
maternal and neonatal outcome. This large retrospective study provides more detail into how 
pregnancy outcome is influenced by different characteristics of fibroid. The presence of 
multiple fibroids is associated with a significantly higher rate of preterm delivery and may 
warrant increased surveillance. How fibroids increase the risk of preterm delivery is however 
unclear.  Mode of delivery and rates of haemorrhage were found to be influenced by location 
of fibroids in the lower part of the uterus. The rates of postpartum haemorrhage, estimated 
blood loss as well as pain were also positively correlated with increasing size of fibroid. Such 
information may be useful in counselling patients and in risk stratification of pregnancies and 
labour. 
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As with previous publications on this topic, our study does have some limitations. These 
include the accuracy of measurement and determination of fibroid type and localisation on 
ultrasound. Missing data was also a problem in this study as a number of patients delivered 
elsewhere and it was not possible to obtain their obstetric outcome. Our statistical power to 
fully examine the association between characteristics of fibroids and pregnancy outcome may 
have been limited by small sample size.  We also cannot rule out the potential effect of 
residual confounders. Nevertheless, this study provides clinically useful data which may be of 
help to other practitioners. 
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Table 1 Relationship between number of fibroids and obstetric outcomes 
 Multiple fibroids n=85 
 
Single fibroid n=51 
 
 
Mean birthweight, kg 
 
3.00 (0.865) 3.18 (0.653) p>0.5 
Preterm labour 
<37/40 
15 (18%) 3 (6%) p=0.05
 
Mode of delivery 
SVD 
 
30 (35%) 
 
20 (39%) 
 
P=0.65 
Caesarean section 46 (54%) 23 (45%) P=0.31 
Instrumental 9 (11%) 8 (16%) p=0.38 
PPH 
 
13 (15%) 6 (12%) p=0.57 
Mean EBL, mls 
 
642 (426) 639 (480) p>0.2 
Admissions due to 
fibroid pain 
10 (12%) 5 (10%) p=0.72 
n = number of live births; SVD = spontaneous vaginal delivery; PPH = postpartum 
haemorrhage; EBL =estimated blood loss;  
Data shown as mean (SD) or number (%) 
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Table 2 Relationship between location of fibroids within the uterus and obstetric outcomes 
n = number of live births; SVD = spontaneous vaginal delivery; PPH = postpartum 
haemorrhage; EBL =estimated blood loss;  
Data shown as mean (SD) or number (%) 
 
 
 
 
 
 
 
 
 
Lower uterus/cervix 
n = 31 
Body of uterus 
n = 104 
 
Mean birthweight, kg 
 
3.00 (0.597) 3.08 (0.827) p>0.5 
Preterm labour 
<37/40 
3 (8%) 15 (14%) p=0.5
 
Mode of delivery 
SVD 
                
4 (13%) 
 
46 (44%) 
 
P=0.0015
 
Caesarean section 26 (84%) 42 (40%) P<0.001
 
Instrumental 1 (3%) 16 (15%) p=0.073 
PPH 
 
8 (22%) 11 (11%) p=0.03
 
Mean EBL, mls 
 
830 (551) 573 (383) p=0.03 
Admissions due to 
fibroid pain 
2 (5%) 13 (12.5%) p=0.35 
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Table 3 Relationship between type of fibroid and obstetric outcomes 
 
n = number of live births; SVD = spontaneous vaginal delivery; PPH = postpartum 
haemorrhage; EBL =estimated blood loss 
Data shown as mean (SD) or number (%) 
 
 
 
 
 
 
 
Intramural 
n=43 
Subserosal/Intramural 
n=51 
Subserosal 
n=32 
 
Mean birthweight, 
kg 
 
3.08 (0.677) 3.03 (0.890) 3.05 (0.821) P=0.96 
Preterm labour 
<37/40 
5 (12%) 9 (18%) 4 (12.5%)
 
p=0.67
 
Mode of delivery 
SVD 
 
19 (44%) 
 
14 (27%) 
 
15 (47%)
 
 
P=0.12
 
Caesarean section 20 (47%) 31 (61%) 11 (34%) P=0.059
 
Instrumental 4 (9%) 6 (12%) 6 (19%) p=0.46 
PPH 
 
4 (9%) 7 (14%) 2 (6%)
 
p=0.53
 
Mean EBL, mls 
 
751 (582) 606 (364) 507 (312) P=0.09 
Admissions due to 
fibroid pain 
7 (16%) 5 (10%) 2 (6%) p=0.36 
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Table 4 Relationship between size of fibroid and obstetric outcomes 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
n = number of live births; SVD = spontaneous vaginal delivery; PPH = postpartum 
haemorrhage; EBL =estimated blood loss;  
Data shown as mean (SD) or number (%) 
 
 
 
 
 
 
 
4 –7 cm 
n=91 
7–10 cm  
n=31 
>10cm  
n=14 
 
Mean birthweight, 
kg 
 
3.10 (0.767) 2.90 (0.482) 3.13 (0.895) P=0.43 
Preterm labour 
<37/40 
10 (11%) 7 (23%) 1 (7%) p=0.2
 
Mode of delivery 
SVD 
 
38 (42%) 
 
7 (23%) 
 
5 (36%)
 
 
P=0.15
 
Caesarean section 44 (48%) 17 (55%) 8 (57%) P=0.72
 
Instrumental 9 (10%) 7 (22%) 1 (7%) p=0.15 
PPH 
 
10 (11%) 4 (13%) 5 (36%)
 
p=0.04
 
Mean EBL, mls 
 
567 (365) 643 (365) 961 (764) P=0.01
 
Admissions due to 
fibroid pain 
5 (5%) 7 (23%) 3 (21%) p=0.01
 
